Drug intelligence / Profile preview

(5Z)-7-oxozeaenol

Development stage
Preclinical
Modality
Small Molecules
Administration
Intracerebroventricular (experimentally), Not Clinically Established
01

Overview

**(5Z)-7-oxozeaenol** is a resorcylic acid lactone of fungal origin, specifically isolated from *Curvularia* species, and acts as a highly potent, selective, irreversible, and ATP-competitive inhibitor of transforming growth factor-β-activated kinase 1 (TAK1, a MAPKKK). It exhibits strong anti-inflammatory and cytotoxic properties, inhibits the NF-κB signaling pathway, and blocks the production of pro-inflammatory cytokines (IL-17A, IFN-γ, TNF-α, IL-6). It also inhibits other kinases such as VEGF receptor 2 (VEGFR2) and PDGFRβ, but with less potency. (5Z)-7-oxozeaenol has demonstrated efficacy in animal models of CNS autoimmune diseases (such as experimental autoimmune encephalomyelitis, EAE—a model of multiple sclerosis), alleviating symptoms by reducing CNS inflammation, demyelination, and microglial activation[1][3][4][5][6].

Other names
(5Z)-7-Oxozeaenol5Z-7-OxozeaenolCHEBI:67559
02

Targets

MAP2K7 (Dual specificity mitogen-activated protein kinase kinase 7)MEK1 (Dual specificity mitogen-activated protein kinase kinase 1)MAPK3 (Mitogen-activated protein kinase 1)VEGFR2 (Vascular endothelial growth factor receptor 2)TAK1 (Transforming growth factor beta–activated kinase 1)

Beyond the preview

Go deeper on (5Z)-7-oxozeaenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (5Z)-7-oxozeaenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call